Financial reports
ARS
2023 FY
Annual report to shareholders
22 Apr 24
10-K
2023 FY
Annual report
26 Mar 24
10-Q
2023 Q3
Quarterly report
13 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
27 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
10-Q
2022 Q1
Quarterly report
16 May 22
Current reports
8-K
Results of Operations and Financial Condition
26 Mar 24
8-K
Corporate Presentation March 2024 1
19 Mar 24
8-K
Departure of Directors or Certain Officers
1 Feb 24
8-K
Corporate Presentation January 2024 1
12 Jan 24
8-K
Regulation FD Disclosure
8 Jan 24
8-K
Corporate Presentation December 2023 1
4 Dec 23
8-K
Corporate Presentation November 2023 1
13 Nov 23
8-K
Acumen Pharmaceuticals Reports Third Quarter 2023 Financial Results and Business Highlights
13 Nov 23
8-K
Entry into a Material Definitive Agreement
8 Nov 23
8-K
Acumen Pharmaceuticals Reports Second Quarter 2023 Financial Results and Business Highlights
8 Aug 23
Registration and prospectus
S-3
Shelf registration
27 Mar 24
S-8
Registration of securities for employees
27 Mar 24
424B5
Prospectus supplement for primary offering
20 Jul 23
424B5
Prospectus supplement for primary offering
17 Jul 23
424B5
Prospectus supplement for primary offering
27 Apr 23
S-8
Registration of securities for employees
28 Mar 23
S-3
Shelf registration
1 Jul 22
S-8
Registration of securities for employees
29 Mar 22
S-8
Registration of securities for employees
2 Jul 21
424B4
Prospectus supplement with pricing info
2 Jul 21
Proxies
DEFA14A
Additional proxy soliciting materials
22 Apr 24
DEF 14A
Definitive proxy
22 Apr 24
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
PRE 14A
Preliminary proxy
14 Apr 23
DEFA14A
Additional proxy soliciting materials
27 Apr 22
DEF 14A
Definitive proxy
27 Apr 22
Other
EFFECT
Notice of effectiveness
25 Apr 24
EFFECT
Notice of effectiveness
11 Jul 22
UPLOAD
Letter from SEC
6 Jul 22
CORRESP
Correspondence with SEC
6 Jul 22
EFFECT
Notice of effectiveness
1 Jul 21
SEC STAFF
SEC staff action: Order
30 Jun 21
CERT
Certification of approval for exchange listing
29 Jun 21
CORRESP
Correspondence with SEC
28 Jun 21
CORRESP
Correspondence with SEC
28 Jun 21
CORRESP
Correspondence with SEC
24 Jun 21
Ownership
SC 13G/A
Deep Track Capital, LP
14 Feb 24
SC 13G
FRANKLIN RESOURCES INC
6 Feb 24
4
James J. Doherty
1 Feb 24
3
James J. Doherty
1 Feb 24
SC 13G/A
MURRAY JAMES B JR
24 Jan 24
4
Daniel Joseph OConnell
19 Jan 24
4
Derek M Meisner
19 Jan 24
4
Matt Zuga
19 Jan 24
4
Eric Siemers
19 Jan 24
4
Russell Barton
19 Jan 24